This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (2473) Human Factors and Usability Case Studies (581) Focus Groups and Qualitative Research with Users (638) Usability Evaluation Case Studies (150) User-centred Design Case Studies (496) Chemotherapy and Side Effects Management (46) Innovations and Technology in Cancer Care (330)

Published on in Vol 21 , No 3 (2019) :March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9958, first published .
User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients

User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients

User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients

Authors of this article:

Rebecca M Prince 1, 2 Author Orcid Image ;   Anthony Soung Yee 2 Author Orcid Image ;   Laura Parente 2 Author Orcid Image ;   Katherine A Enright 3 Author Orcid Image ;   Eva Grunfeld 1, 4 Author Orcid Image ;   Melanie Powis 2 Author Orcid Image ;   Amna Husain 1 Author Orcid Image ;   Sonal Gandhi 5 Author Orcid Image ;   Monika K Krzyzanowska 1, 2 Author Orcid Image
Article Authors Cited by (2) Tweetations (6) Metrics

Journals

  1. Robinson A, Husband A, Slight R, Slight S. Designing Digital Health Technology to Support Patients Before and After Bariatric Surgery: Qualitative Study Exploring Patient Desires, Suggestions, and Reflections to Support Lifestyle Behavior Change. JMIR Human Factors 2022;9(1):e29782 View
  2. Antonuzzo A, Ripamonti C, Roila F, Sbrana A, Galli L, Miccinesi G, Sammarco E, Berruti A, Coletta D, Velutti L, Fabi A, Corsi D, Mariani G, Di Pede P, Spinelli G, Santini D, Zustovich F, Gunnellini M, Rossi M, Giordano M, Di Maio M, Numico G, Bossi P. Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. Frontiers in Oncology 2022;12 View